Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;19(Suppl 1):S7-S15.
doi: 10.3747/co.19.1069.

The importance of multidisciplinary team management of patients with non-small-cell lung cancer

The importance of multidisciplinary team management of patients with non-small-cell lung cancer

P M Ellis. Curr Oncol. 2012 Jun.

Abstract

Historically, a simple approach to the treatment of non-small-cell lung cancer (nsclc) was applicable to nearly all patients. Recently, a more complex treatment algorithm has emerged, driven by both pathologic and molecular phenotype. This increasing complexity underscores the importance of a multidisciplinary team approach to the diagnosis, treatment, and supportive care of patients with nsclc. A team approach to management is important at all points: from diagnosis, through treatment, to end-of-life care. It also needs to be patient-centred and must involve the patient in decision-making concerning treatment. Multidisciplinary case conferencing is becoming an integral part of care. Early integration of palliative care into the team approach appears to contribute significantly to quality of life and potentially extends overall survival for these patients. Supportive approaches, including psychosocial and nutrition support, should be routinely incorporated into the team approach. Challenges to the implementation of multidisciplinary care require institutional commitment and support.

Keywords: Non-small-cell lung cancer; multidisciplinary care.

PubMed Disclaimer

References

    1. Canadian Cancer Society’s Steering Committee on Cancer Statistics . Canadian Cancer Statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
    1. Cataldo JK, Slaughter R, Jahan TM, Pongquan VL, Hwang WJ. Measuring stigma in people with lung cancer: psychometric testing of the Cataldo lung cancer stigma scale. Oncol Nurs Forum. 2011;38:E46–54. doi: 10.1188/11.ONF.E46-E54. - DOI - PMC - PubMed
    1. Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ. 2004;328:1470. doi: 10.1136/bmj.38111.639734.7C. - DOI - PMC - PubMed
    1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-Small Cell Lung Cancer Collaborative Group BMJ. 1995;311:899–909. - PMC - PubMed
    1. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase iii trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004;22:1589–97. doi: 10.1200/JCO.2004.08.163. - DOI - PubMed

LinkOut - more resources